The role of miR-143-3p/FNDC1 axis on the progression of non-small cell lung cancer

In conclusion, FNDC1 promotes the malignant prototypes of NSCLC cells. miR-143-3p is a negative regulator of FNDC1 in NSCLC cells, which may serve as a promising therapeutic target in NSCLC.
Source: European Journal of Histochemistry - Category: Biomedical Science Authors: Source Type: research